Corvus Pharmaceuticals Cash Flow | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc. | Cash Flow

No data

About Corvus Pharmaceuticals

View Profile

Address	863 Mitten Road Burlingame California 94010 United States
Employees	-
Website	http://www.corvuspharma.com
Updated	07/08/2019
Corvus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of small molecule and antibody agents that target crucial enzymes and proteins in the immune system to treat patients with cancer. Its product pipeline includes Adenosine A2A Receptor Antagonist CPI-444, Adenosine Production Inhibitor Anti-CD73, Adenosine A2B Receptor Antagonist, ITK Inhibitor, and Myeloid Cell Suppression. The company was founded by Richard A.